Our finding is that the mature myeloma cell (CD138+, rapidly proliferating and chemosensitive) has developmental plasticity; namely, the ability to dedifferentiate back into its own chemoresistant CSC progenitor, the CD138–, quiescent plasma cell that possesses stemness potential. Here, SDC1 is linked to plasma cell myeloma.